| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.4 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.048 | 0.4 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.045 | 0.4 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |